Rachel has 5+ years of experience in life sciences strategy consulting, supporting biopharma clients as they develop and commercialize innovative new therapies. Prior to joining Asymmetry, she was a consultant at Artisan, an Alira Health Company, where her work focused on new product planning as well as opportunity assessments for business development. Her past work has included indication prioritization, forecast creation, and direct engagement with stakeholders through market research and advisory board facilitation. Rachel has supported clients of all sizes across therapeutic areas, with deep knowledge of the oncology and hematology landscapes. She is motivated by recent and emerging research breakthroughs in difficult-to-treat diseases and is eager to support clients in bringing these therapies to market. She holds a B.A. in Biology from Brown University. Outside of work, Rachel enjoys trying new restaurants across Boston neighborhoods, going to yoga classes, and knitting sweaters to brave New England winters.
